Fresenius Medical Care is on course to extend its four-day winning streak today; currently up 0.34% at around $23.65

After closing the previous trading day at $23.57, Fresenius Medical Care is up to $23.65, which makes for a move of 0.34%/8 cents today.

Fresenius Medical Care's uptick comes amid good United States macroeconomic data released during the day — data for United States Retail Sales released yesterday at 12:30 UTC is better than expected with 0.3%, but worse than previous figure of 0.4%.

On the flip side, new United States Initial Jobless Claims data fell short of the 250,000 projected by analysts with a reading of 262,000 while failing to improve upon the previous reading from last month (262,000).

At the same time, United States Philadelphia Fed Manufacturing Index (Jun) released yesterday at 12:30 UTC with a figure of -13.7, while the previous figure was -10.4.

Trend and momentum analysis indicates that the Commodity Channel Index (CCI) indicator is above +100, meaning the market price is unusually high compared to the rolling average. According to asset volatility analysis, Bollinger Band® analysis indicates that current price action is approaching the upper band at $23.96, thereby suggesting that Fresenius Medical Care is becoming overvalued.

Overall, while Fresenius Medical Care has been on an uptrend, technical indicators suggest that it has no obvious direction for the immediate future.

This rally in Fresenius Medical Care's share price coincides with other health care stocks as Eli Lilly and Company gained 1.39%, currently at $453.93. Sanofi is up 1.41%. Novartis is up 0.97%.

This year has been a bright one for the US-German healthcare company after trading as low as $12.81 and going on to appreciate by 46.31% year to date.